Journal of Hepatology
Volume 53, Issue 2 , Pages 219-220 , August 2010

Focus

Received 27 April 2010 ,Accepted 27 April 2010.

References 

  1. Abbas G, Lindor KD. Cholangiocarcinoma in primary sclerosing cholangitis. J Gastrointest Cancer. 2009;40(1–2):19–25
  2. Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol. 2009;50:158–164
  3. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10
  4. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?. J Hepatol. 2004;40:472–477
  5. Rudolph G, Gotthardt D, Klöters-Plachky P, Kulaksiz H, Rost D, Stiehl A. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol. 2009;51:149–155

PII: S0168-8278(10)00387-9

doi: 10.1016/j.jhep.2010.04.005

Journal of Hepatology
Volume 53, Issue 2 , Pages 219-220 , August 2010

Article Tools